Real-World Experience with Nivolumab in Metastatic Renal Cell Carcinoma Patients Who Have Progressed on Prior Therapies: A Single-Center Study from India

Abstract Amit Rauthan Introduction Nivolumab monotherapy is approved for the treatment of metastatic renal cell carcinoma (mRCC) patients who have progressed on prior therapies based on the pivotal Ch...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Amit Rauthan, Nitin Yashas Murthy, Poonam Patil, Gaurav Nigade, SP Somashekhar, Shabber S. Zaveri
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-04-01
coleção:	South Asian Journal of Cancer
Assuntos:	nivolumab metastatic rcc iraes immunotherapy indian experience
Acesso em linha:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1740373
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!